Skip to main content
NCBI home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Mar 12.
Published in final edited form as: Cell Struct Funct. 2017 Mar 7;42(1):49–60. doi: 10.1247/csf.17003

PI5P and PI(3,5)P2: Minor, but Essential Phosphoinositides

Junya Hasegawa 1,*, Bethany S Strunk 1, Lois S Weisman 1,*
PMCID: PMC5846621  NIHMSID: NIHMS948220  PMID: 28302928

Abstract

In most eukaryotes, phosphoinositides (PIs) have crucial roles in multiple cellular functions. Although the cellular levels of phosphatidylinositol 5-phosphate (PI5P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) are extremely low relative to some other PIs, emerging evidence demonstrates that both lipids are crucial for the endocytic pathway, intracellular signaling, and adaptation to stress. Mutations that causes defects in the biosynthesis of PI5P and PI(3,5)P2 are linked to human diseases including neurodegenerative disorders. Here, we review recent findings on cellular roles of PI5P and PI(3,5)P2, as well as the pathophysiological importance of these lipids.

Keywords: Phosphoinositides, Membrane trafficking, Endocytosis, Vacuoles/Lysosomes, Fab1/PIKfyve

Introduction

Cellular organelles, including endosomes, lysosomes, and mitochondria, are membrane-bound compartments that maintain specialized sub-environments within the cell. Membranes are composed of proteins and lipids. Membrane lipids include cholesterol, glycerophospholipids, and sphingolipids that include sphingomyelin (van Meer et al, 2008), which function in part to maintain the structural integrity of organelles. In addition, some membrane lipids function as key effectors that regulate intracellular signaling as well as remodeling of the cytoskeleton (Eyster, 2007; Fernandis & Wenk, 2007).

Phosphorylated derivatives of phosphatidylinositol, called phosphoinositides (PIs), form a family of acidic phospholipids embedded in membranes. Despite their rarity compared to other phospholipids such as phosphatidylcholine and phosphatidylethanolamine (phosphatidylinositol makes up approximately 10–20% of total cellular phospholipids), PIs have an indispensable role in cellular processes. Seven PIs, differing in phosphorylation at the 3-, 4-, and 5-hydroxyls of the inositol head group, have been detected in cells (Di Paolo & De Camilli, 2006; Sasaki et al, 2009; Mayinger, 2012; Balla, 2013; Schink et al, 2016). Production and turnover of PIs by phosphorylation and dephosphorylation is spatiotemporally regulated through the controlled action of PI kinases, phosphatases, and phospholipases (Fig. 1). PIs are localized at cytosolic leaflet of distinct membranes (Fig. 2) and can recruit effector proteins to membranes to modulate intracellular signaling as well as membrane dynamics (Balla, 2013; Tsujita & Itoh, 2015; Schink et al, 2016).

Fig. 1.

Fig. 1

Open in a new tab

Interconversion pathways of seven phosphoinositide lipids. The action of lipid kinases is indicated as red arrows, and the action of phosphatases is indicated as blue arrows. The action of phospholipase C (PLC) is indicated by a green arrow.

Fig. 2.

Fig. 2

Open in a new tab

Phosphoinositides are localized at distinct sites within the intracellular membrane system. The reported localization of each phosphoinositide is shown as the color indicated in the key.

Determination of the functions of phosphatidylinositol 5-phosphate (PI5P) or phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), has advanced slowly relative to other PIs, due to their low abundance and limitations in their detection including a lack of bioprobes specifically recognizing these lipids. Moreover, there are no methods currently available to solely deplete PI5P or PI(3,5)P2. Despite these limitations, hundreds of recent studies demonstrate that these minor PIs have important and intriguing cellular roles. This review summarizes and discusses current findings on the physiological and pathological roles of PI5P and PI(3,5)P2.

Phosphatidylinositol 5-phosphate (PI5P)

Regulation of PI5P synthesis and turnover

PI5P is the most recently detected of the seven known PIs, and is present at levels similar to PI3P (approximately 0.5% of total PI) in mammalian cells (Zolov et al, 2012; McCartney et al, 2014b). PI5P was discovered in mammalian NIH-3T3 cells in 1997 (Rameh et al, 1997). The same report revealed that, in vitro, PI5P is a substrate of type II PIP kinase (PI5P 4-kinase), which generates PI(4,5)P2. Most cellular pools of PI5P depend on the activity of the lipid kinase PIKfyve. Direct phosphorylation of PI at the 5-position by PIKfyve has been proposed to be the primary source of PI5P (Sbrissa et al, 1999; 2002). An alternative model proposes that most PI5P is generated by PIKfyve indirectly. According to the indirect model, most pools of PI5P are derived from 3-phosphatase mediated dephosphorylation of PI(3,5)P2, which is produced by PIKfyve catalyzed phosphorylation of PI3P. (Schaletzky et al, 2003; Tronchère et al, 2004; Vaccari et al, 2011; Zolov et al, 2012; Oppelt et al, 2013). Importantly, in either scenario, depletion or inhibition of PIKfyve simultaneously lowers the cellular levels of PI5P and PI(3,5)P2.

Cellular levels of PI5P can be altered by pathogen infection. Some virulence factors of invasive bacterial pathogens change the host levels of PI5P through the type III secretion system (Norris et al, 1998; Marcus et al, 2001; Niebuhr et al, 2002). These factors facilitate invasion of host cells by manipulating host phospholipid metabolism in order to direct actin remodeling and modify their uptake machinery (Cossart & Sansonetti, 2004). The Shigella flexneri virulence factor IpgD converts PI(4,5)P2 to PI5P in vitro and in vivo (Niebuhr et al, 2002). Interestingly, expression of IpgD in mammalian cells elevates intracellular levels of PI5P as measured by HPLC (Niebuhr et al, 2002; Pendaries et al, 2006; Viaud et al, 2014) or by an in vitro mass assay (Vaccari et al, 2011). Exogenous expression of IpgD to increase PI5P levels has been used to analyze the function of PI5P in mammalian cells. However, it is not known whether these increased pools of PI5P are produced at the proper intracellular location. The homologues of IpgD in Salmonella dublin and Salmonella typhimurium are SopB and SigD, respectively (Norris et al, 1998; Marcus et al, 2001). Each of these virulence factors contains the consensus sequence for 4-phosphatases (C-X-X-X-X-X-R; X is not an acidic residue), and prefer PI(4,5)P2 as a substrate over other PIs, supporting the model that these virulence factors generate PI5P from PI(4,5)P2. A search for similar proteins in mammalian databases led to the identification of type I and type II PI(4,5)P2 4-phosphatases in mammalian cells (Ungewickell et al, 2005). Both proteins dephosphorylate PI(4,5)P2 to generate PI5P in vitro. These 4-phosphatases localize to lysosomes and are involved in epidermal growth factor (EGF) receptor degradation, suggesting that these enzymes, and perhaps the lipid species they produce, are involved in degradation pathways. However, in vivo conversion of PI(4,5)P2 to PI5P by these phosphatases has not yet been demonstrated and their mechanistic roles remain to be determined.

PI5P 4-kinases (PI5P4Ks) are conserved from flies and worms to humans. Mammals have three PI5P4K isoforms (α, β, and γ) (Lecompte et al, 2008; Clarke & Irvine, 2013). PI5P4Ks prefer PI5P as a substrate and can generate PI(4,5)P2 in vitro and in vivo (Rameh et al, 1997; Roberts et al, 2005; Sarkes & Rameh, 2010). The contribution of these PI5P4Ks to total intracellular levels of PI(4,5)P2 is reported to be minor and it has been proposed that their primary cellular function might be to reduce PI5P.

Changes in PI5P levels upon stress

Cellular levels of PI5P can be altered by extracellular stimulation. For instance, thrombin induced platelet aggregation at sites of vascular injury is associated with a 3-fold increase in the levels of PI5P as measured by an in vitro mass assay (Morris et al, 2000). Interestingly, the increase of PI5P is acute (peaking at 5 minutes after stimulation), suggesting that this lipid may stimulate platelet aggregation. Hyperosmotic stress has been shown to increase the PI5P levels in plants (Meijer et al, 2001) and hypo-osmotic shock induces a significant decrease of PI5P levels in mammalian cells (Sbrissa et al, 2002), as measured by an in vitro mass assay. Changes in PI5P levels resulting from osmotic stress are acute (within 10 minutes), implying that PI5P plays early roles in adaptation to osmotic shock. In response to oxidative stress, such as hydrogen peroxide (H2O2), PI5P levels are transiently elevated, whereas the levels of PI(4,5)P2 are decreased as measured by HPLC (Sarkes & Rameh, 2010; Jones et al, 2013), suggesting that the source of H2O2-induced PI5P is PI(4,5)P2. In addition, exposure to insulin causes a transient increase of PI5P in 3T3-L1 adipocytes by an in vitro mass assay (Sbrissa et al, 2004), CHO cells stably expressing insulin receptor by HPLC (Sarkes & Rameh, 2010), and skeletal muscle cells by an in vitro mass assay (Grainger et al, 2011). Together these data suggest that PI5P is an important second messenger regulating intracellular signaling pathways in response to stress. However, the mechanisms of the synthesis and turnover of PI5P during diverse stresses are not known.

Intracellular localization of PI5P

PI5P was initially discovered to have a signaling role in the nucleus (Clarke et al, 2001; Gozani et al, 2003; Jones et al, 2006). A plant homeodomain (PHD) finger of the chromatin-associated protein ING2 strongly binds to PI5P in vitro and in vivo. Importantly, the interaction of ING2 with PI5P regulates a p53-dependent apoptotic pathway, suggesting that ING2 functions as a nuclear receptor for PI5P (Gozani et al, 2003). Furthermore, PI5P4Kβ, which localizes to the nucleus (Ciruela et al, 2000), modulates nuclear levels of PI5P, regulating the association of ING2 and chromatin in response to cellular stress such as UV irradiation (Jones et al, 2006). Notably, nuclear levels of PI5P increase in cells during the G1 phase of the cell cycle (Clarke et al, 2001), indicating that this lipid might be involved in regulation of the cell cycle.

Biochemical subcellular fractionation, combined with HPLC detection, revealed that PI5P is also present at the plasma membrane as well as on non-nuclear intracellular membrane compartments including the endoplasmic reticulum and Golgi apparatus (Sarkes & Rameh, 2010). Consistent with this finding, several reports indicate relationships between PI5P and the plasma membrane as well as the endomembrane system. The localization of the PI5P binding peptide ING2 PHD indicates that PI5P is concentrated at host cell entry sites during early phases of infection by S. flexner, which involve injection of the virulence factor IpgD to remodel the actin cytoskeleton (Niebuhr et al, 2002; Pendaries et al, 2006). The localization of PI5P at the plasma membrane and early endosomes is also supported by recruitment of the PI5P binding protein Tiam1 to these compartments (Viaud et al, 2014). Upregulation of PI5P induced by introduction of the virulence factor IpgD enhances the internalization of the EGF receptor from the cell surface to early endosomes, but suppresses the maturation of early endosomes to late endosomes (Ramel et al, 2011; Boal et al, 2015). Moreover, elevation of PI5P alters actin and membrane dynamics at the plasma membrane to promote cell migration (Oppelt et al, 2013; Viaud et al, 2014).

PI5P has also been reported to be involved in autophagy. A recent study shows that PI5P localizes to autophagosomes and activates autophagy (Vicinanza et al, 2015). Moreover, this report shows that depletion of PI5P4Ks, especially PI5P4Kγ, which phosphorylates PI5P to produce PI(4,5)P2, enhances autophagy and reduces aggregates of mutant huntingtin associated with Huntington’s disease.

Taken together, these data suggest PI5P is localized to the nucleus and to non-nuclear membranes including the plasma membrane and early endosomes. It is clear that, although cellular levels of this lipid are quite low compared to other PIs, PI5P plays crucial roles at each of these compartments including remodeling of the actin cytoskeleton, endocytosis, and nuclear signaling.

Physiological and pathological roles of PI5P

Insulin stimulation, which leads to increased cellular PI5P (Sbrissa et al, 2004; Sarkes & Rameh, 2010; Grainger et al, 2011), causes translocation of the glucose transporter GLUT4 from intracellular compartments to the plasma membrane enhancing glucose uptake from extracellular fluid (Leney & Tavaré, 2009). Intriguingly, the microinjection of PI5P, but not other PIs, into cells induces GLUT4 translocation to the plasma membrane (Sbrissa et al, 2004; Grainger et al, 2011). Moreover, insulin-induced GLUT4 localization to the cell surface is completely blocked in 3T3-L1 adipocytes expressing ING2 PHD (Sbrissa et al, 2004), a PI5P binding peptide predicted to interfere with PI5P binding to appropriate effectors. In addition, the increase in PI5P levels and glucose uptake induced by insulin stimulation are abolished in L6 myotubes by the expression of PI5P4Kα, which removes PI5P by phosphorylating it to generate PI(4,5)P2 (Grainger et al, 2011). These studies demonstrate that PI5P is a key factor regulating insulin-induced glucose uptake through the translocation of GLUT4 vesicles in both adipocytes and myotube cells.

As described above, virulence factors secreted by some pathogens alter specific host pathways through elevation of PI5P. IpgD from S. flexneri generates PI5P from PI(4,5)P2 inducing membrane blebbing and actin remodeling (Niebuhr et al, 2002). Moreover, ectopic expression of IpgD or the addition of short-chain penetrating PI5P induces the activation of the PI 3-kinase/Akt pathway, which promotes long-term survival of the host cells, potentially facilitating efficient replication of the bacteria (Pendaries et al, 2006). It was also recently reported that S. flexneri infection accelerates the internalization and degradation of the intercellular adhesion molecule-1 (ICAM-1), an essential factor in immune cell recruitment, in an IpgD-dependent manner (Boal et al, 2016). Importantly, the reduction of cell surface ICAM-1 by IpgD decreases neutrophil recruitment to the apical side of the epithelial cells, suggesting that pathogen induced increases in PI5P in host cells may serve to protect infected cells from the immune system. Thus, PI5P production (or decreased PI(4,5)P2) in the host cell is beneficial for invasive bacteria on multiple levels. PI5P and the factors responsible for its production including IpgD are therefore potential drug targets for the treatment and prevention of bacteria-associated diseases.

T cells, a major cell type in the immune system, are strongly activated through T cell receptor (TCR) stimulation by antigen presenting cells, such as dendritic cells and macrophages, promoting T cell maturation. The stimulation of TCR on T cells induces the activation of protein kinases including Akt and mTORC1, which control cell adhesion and gene expression (Acuto et al, 2008). Downstream of tyrosine kinase (Dok) proteins Dok-1 and Dok-2 also regulate T cell signaling (Acuto et al, 2008). It has been reported that the PH domains of Dok-1/Dok-2 are essential for them to be phosphorylated and for T cell signaling (Guittard et al, 2009). Interestingly, both PH domains bind to PI5P in vitro and elevation of PI5P through expression of IpgD results in an increase in tyrosine phosphorylation on Dok-1/Dok-2. In addition, IpgD-induced increases in PI5P cause the activation of Src kinase and Akt, and stimulate interleukin II promoter activity in T cells (Guittard et al, 2010). These studies indicate that PI5P is required to maintain T cell homeostasis through modification of T cell signaling.

Several pathogen components, such as lipopolysaccharides (LPS; a major component of the outer cell wall of gram-negative bacteria) and dsRNA from the genomes of dsRNA viruses, are detected by innate immune receptors including Toll-like receptors (TLRs) (Kawai & Akira, 2011; Kondo et al, 2012). Stimulation by either LPS or poly I:C (a synthetic analog of dsRNA), to mimic infection, results in increased cellular PI5P (Kawasaki et al, 2013). The suppression of PIKfyve, which is either directly or indirectly responsible for PI5P generation, impairs intracellular signaling triggered by TLRs, such as activation of interferon regulatory factor and NF-κB transcription factor, both of which control expression of the cytokine genes (Kawasaki et al, 2013). In addition, exogenous administration of synthetic PI5P induces the production of interferon β. These data suggest that PI5P is a critical signal in the innate immune response.

PI5P-binding proteins and their potential use as PI5P probes

Several proteins/domains bind to PI5P in vitro (Table I). The PHD finger of ING2 (ING2 PHD) is a potent binder of PI5P both in vitro and in vivo (Gozani et al, 2003). ING2 PHD is commonly used as a probe to investigate PI5P localization and function. However, this peptide also weakly binds PI3P and PI4P in vitro, which raises questions of whether ING2 PHD is an ideal PI5P probe. Intriguingly, the PHD finger of ATP-dependent chromatin remodeling factor (ACF) strongly and specifically interacts with PI5P in a protein-lipid overlay (PLO) assay (Gozani et al, 2003), suggesting that it could have potential for use as an in vivo probe for PI5P. The PH domains of Dok proteins bind mono-phosphoinositides including PI5P (Guittard et al, 2009; 2010) and, among these, the PH domain of Dok-5 displays the highest binding affinity for PI5P, as measured by PLO assay and surface plasmon resonance. The PH domain of Tiam1, a GEF of Rac1, also has high affinity for PI5P (Viaud et al, 2014), however, it also has a high affinity for PI3P (Baumeister et al, 2003; Viaud et al, 2014) indicating that this domain would be unsuitable for a PI5P specific probe. TOM1 has recently been reported to bind PI5P with an affinity that is two-fold higher than that observed with other mono-phosphoinositides (Boal et al, 2015). Thus, there is potential for the use of the VHS (Vps27-Hrs-STAM) domain of TOM1 as a probe for PI5P.

Table I.

Binding proteins/domains to PI5P

Proteins/domains Binding affinity References
ING2 PHD PI5P ≫ PI3P, PI4P Gozani et al, 2003
ACF PHD PI5P Gozani et al, 2003
Dok-1 PH domain PI4P, PI5P > PI3P Guittard et al, 2009
Dok-2 PH domain PI4P, PI5P > PI3P Guittard et al, 2009
Dok-4 PH domain PI5P > PI3P, PI4P Guittard et al, 2010
Dok-5 PH domain PI5P ≫ PI3P, PI4P Guittard et al, 2010
Tiam1 PH domain PI5P > PI3P Viaud et al, 2014
TOM1 VHS domain PI5P > PI3P, PI4P Boal et al, 2015
Open in a new tab

In summary, domains with high affinity for PI5P have been identified, but most of these PI5P binding domains also bind other mono-phosphoinositides. Further work is needed to find a potent specific PI5P binding probe.

Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2)

Regulation of PI(3,5)P2 synthesis and turnover

PI(3,5)P2 is less abundant than most of the PIs in the cell including PI4P and PI(4,5)P2, and comprises only about 0.05~0.1% of total cellular PI. Fab1 (PIKfyve in mammals) is the PI3P 5-kinase, which phosphorylates PI3P to produce PI(3,5)P2 and is the sole source of this lipid in yeast (Gary et al, 1998; Cooke et al, 1998) and mammalian fibroblasts (Sbrissa et al, 1999; Zolov et al, 2012). In yeast, PI3P is produced by the PI 3-kinase Vps34 (Schu et al, 1993). In mammalian cells Vps34 produces the majority of PI3P (Backer, 2008), and provides most of the pool utilized in the synthesis of PI(3,5)P2 (Ikonomov et al, 2015). The levels of PI(3,5)P2, as well as those of its precursor PI3P and product PI5P, dynamically change upon specific stresses. Moreover dominant active mutations in Fab1 and PIKfyve have been isolated and characterized (Duex et al, 2006b; Lang et al, 2017). Together these findings suggest that Fab1 (PIKfyve) is dynamically and tightly regulated.

PI(3,5)P2 turnover is proposed to be catalyzed by the Sac1 related phosphatase Fig4 (also called Sac3). Dephosphorylation of PI(3,5)P2 at the 5-position to produce PI3P has been reported in vitro (Rudge et al, 2004). However, specific Fig4 mutations in yeast impair both the production and turnover of PI(3,5)P2 (Gary et al, 2002; Duex et al, 2006a; 2006b; Chow et al, 2007) and loss of Fig4 function in mammalian cells results in large reduction of PI(3,5)P2 (Chow et al, 2007; Zolov et al, 2012). Thus, PI(3,5)P2 levels are both positively and negatively regulated by Fig4 function. In mammalian cells, PI(3,5)P2 may also be removed through the activity of MTMR 3-phosphatases (Schaletzky et al, 2003; Tronchère et al, 2004; Vaccari et al, 2011; Oppelt et al, 2013). However, the extent to which MTMRs contribute to PI(3,5)P2 turnover in vivo is not known.

PI(3,5)P2 levels are controlled through Fab1/PIKfyve association with a large protein complex involving several regulatory proteins. In yeast this complex includes Fig4, Vac14, Vac7, and Atg18; Fig4 and Vac14 are conserved in metazoans (Shisheva, 2008; McCartney et al, 2014a; Jin et al, 2016). Vac14, also called ArPIKfyve in mammals, consists almost entirely of HEAT repeats, and functions as a scaffold protein to form a complex with Fab1, Fig4, Vac7, and Atg18. Vac14 binds directly to all of these regulatory proteins (Jin et al, 2008; Botelho et al, 2008) and is required for efficient synthesis of PI(3,5)P2 (Duex et al, 2006a; 2006b). Vac14 forms oligomers (Dove et al, 2002; Jin et al, 2008; Botelho et al, 2008) through its C-terminal region (Alghamdi et al, 2013). The importance of Vac14 oligomerization in the regulation of PI(3,5)P2 production in cells remains unclear. Fig4 positively regulates PI(3,5)P2 production through its association with Vac14 and Fab1/PIKfyve (Duex et al, 2006a; 2006b; Jin et al, 2008; Botelho et al, 2008). MEFs from either Fig4−/− or Vac14−/− mice produce less than half the levels of PI(3,5)P2 compared with wild-type cells, whereas the depletion of PIKfyve completely abolishes the PI(3,5)P2 production (Zhang et al, 2007; Zolov et al, 2012), suggesting that PIKfyve retains some function in the absence of Fig4 and Vac14.

Vac7 in yeast plays an essential but poorly understood role in activation of Fab1 (Gary et al, 2002; Duex et al, 2006a; 2006b). Vac7 is the only protein containing a transmembrane region among the regulatory proteins of Fab1 complex, but has no conserved motifs, and no known metazoan homologues (Gary et al, 2002).

In yeast, Atg18 negatively regulates PI(3,5)P2 levels (Dove et al, 2004) and interacts with Vac14 (Jin et al, 2008). Structure/function analysis revealed that Atg18 has two PI-binding sites (PI3P and PI(3,5)P2 binding) (Dove et al, 2004; Watanabe et al, 2012; Baskaran et al, 2012), which are essential for its localization on vacuole membranes as well as its function as a negative regulator for PI(3,5)P2 synthesis (Efe et al, 2007). Atg18 also has an essential role in autophagy (Klionsky et al, 2003), and this function is retained by the four mammalian Atg18 homologues: WIPI1, WIPI2, WIPI3, and WIPI4 (Proikas-Cezanne et al, 2007; 2015). Mammalian WIPI proteins have not yet been implicated in the regulation of PI(3,5)P2.

In summary, Fab1 forms a complex with Fig4, Vac14, Vac7, and Atg18 in yeast, and PIKfyve forms a complex with Fig4 and Vac14 in mammals, to tightly control the cellular levels of PI(3,5)P2. Although some regulators present in the yeast complex have not been identified in mammals, the fundamental mechanism underlying the maintenance of PI(3,5)P2 levels are highly conserved between these organisms.

Changes in PI(3,5)P2 levels upon stress

In yeast, the levels of PI(3,5)P2 transiently increase in response to hyperosmotic stress (Dove et al, 1997; Bonangelino et al, 2002; Duex et al, 2006a; 2006b; Jin et al, 2008). PI(3,5)P2 peaks at 5–10 minutes of exposure to this stress, then returns to basal levels within 30 minutes. The rapid increase in PI(3,5)P2 depends on Fab1 kinase activity as well as the regulatory proteins in the Fab1 complex including Vac14, Vac7, and Fig4 (Duex et al, 2006a).

Among mammalian cell lines tested, only 3T3-L1 adipocytes demonstrate transient elevation of PI(3,5)P2 in response to hyperosmotic stress (Sbrissa & Shisheva, 2005) suggesting differential regulation of PI(3,5)P2 in different cell types. Insulin stimulation also causes an elevation of PI(3,5)P2 in 3T3-L1 adipocytes (Ikonomov et al, 2007; 2009; Bridges et al, 2012). EGF induces modest elevation of PI(3,5)P2 in COS7 cells (Tsujita et al, 2004), and PI(3,5)P2 is gradually elevated during phagosome formation in macrophages (Samie et al, 2013). These studies indicate that PI(3,5)P2 production and turnover are regulated by different stimuli in different mammalian cell types and suggest that there are likely to be multiple mechanisms for the activation of PIKfyve.

Intracellular localization of PI(3,5)P2 and the Fab1/PIKfyve complex

The factors responsible for PI(3,5)P2 synthesis, including Fab1, Fig4, and Vac14, all localize on the limiting membrane of vacuoles in yeast (Rudge et al, 2004; Jin et al, 2008). Mammalian PIKfyve and Vac14 are reported to localize to early endosomes, late endosomes, and lysosomes (Cabezas et al, 2006; Rutherford et al, 2006; Ikonomov et al, 2006; Zhang et al, 2012). These results predict the presence of PI(3,5)P2 on these organelles.

It was recently proposed that the cytosolic N-terminal region of mucolipin transient receptor potential 1 (TRPML1) (ML1N) may be useful as a PI(3,5)P2 probe (Li et al, 2013). ML1N co-localizes with LAMP1 and its localization is disrupted by treatment with YM-201636, a PIKfyve inhibitor (Jefferies et al, 2008), suggesting that the PI(3,5)P2 is primarily localized to late endosomes and lysosomes.

Takatori et al. developed a method to detect PI(3,5)P2 combining freeze-fracture electron microscopy with the use of tagged Atg18 protein as a PI(3,5)P2 binding probe (Takatori et al, 2016). Atg18 binds to both PI(3,5)P2 and PI3P. In order to improve specificity of Atg18 for PI(3,5)P2, a PI3P binding p40phox PX domain was used to compete with Atg18 binding to PI3P. Using this approach, PI(3,5)P2 was found to be concentrated at specific microdomains of the vacuole membrane in yeast. In addition, in mammalian cells, PI(3,5)P2 was detected at lysosomes, but not other organelles such as mitochondria and the Golgi apparatus. Together, these studies suggest that PI(3,5)P2 is primarily localized to early and late endosomes and lysosomes/vacuoles (Fig. 2).

Physiological and pathological roles of PI(3,5)P2

Vac14−/− mice die within a few days of birth (Zhang et al, 2007), whereas PIKfyve hypomorphic mice (less than 10% of the normal levels of PIKfyve protein), Fig4−/− mice, or Vac14L156R/L156R (ingls), which display less than 50% of the levels of PI(3,5)P2 and PI5P compared to wild-type mice, survive for several weeks (Chow et al, 2007; Jin et al, 2008; Zolov et al, 2012). A whole body knockout mouse of PIKfyve, showing complete loss of PI(3,5)P2, results in death at embryonic stage E3.5 in one strain (Ikonomov et al, 2011) but at stage E7.5-E8.5 in a different mouse strain (Takasuga et al, 2013). These studies suggest that PI(3,5)P2 is crucial for embryonic development and that sufficient levels of PI(3,5)P2 or PI5P are also required at postnatal stages.

Studies of several mouse mutants indicate that the PIKfyve complex has critical functions in both the central and peripheral nervous systems. Vac14−/− mice display massive brain defects, including a spongiform-like appearance and increased apoptosis (Zhang et al, 2007). Fig4−/− and Vac14L156R/L156R (ingls) mice, a mutant that prevents the interaction of Vac14 with PIKfyve, as well as PIKfyve hypomorphic mice, which have decreased but not complete loss of PI(3,5)P2 and PI5P, exhibit similar neurodegeneration (Chow et al, 2007; Jin et al, 2008; Ferguson et al, 2009; Lenk et al, 2011; Zolov et al, 2012). These observations demonstrate that nervous system defects are a prominent phenotype resulting from disruption of the PIKfyve complex. Additional tissues are also affected. Intestine-specific depletion of PIKfyve results in increased vacuolation as well as inflammation and fibrosis in the intestine resulting in malnutrition and a lean phenotype (Takasuga et al, 2013). Moreover, PIKfyve hypomorphic mice display large vacuoles and spongiform degeneration in the heart and reduction of airspace in the lung (Zolov et al, 2012). The spleen from Fig4−/− mice or the PIKfyve hypomorph is small and has reduced density compared to wild-type (Chow et al, 2007; Zolov et al, 2012). Interestingly, pigment-containing hair follicles and melanosomes in hair are significantly reduced in Fig4−/− mice (Chow et al, 2007), which suggests that the PIKfyve complex might be involved in the biogenesis of melanosomes. Platelet-specific deletion of PIKfyve induces inflammation and thrombosis, which are caused by impaired release of lysosomal enzymes in platelets (Min et al, 2014). Thus, PI(3,5)P2 plays important roles in multiple tissue types.

The discovery of PIKfyve inhibitors such as YM-201636 (Jefferies et al, 2008), MF4 (de Lartigue et al, 2009), and apilimod (Cai et al, 2013) has greatly contributed to determining the cellular functions of PI(3,5)P2. The most notable phenotype of Fab1/PIKfyve suppression is enlarged vacuoles/lysosomes (Bonangelino et al, 2002; Duex et al, 2006b; Rutherford et al, 2006; Zhang et al, 2007). Overexpression of the TRPML1 calcium channel rescues the enlarged lysosome phenotype observed in PI(3,5)P2-deficient MEFs (Dong et al, 2010), indicating that the increased size of vacuoles/lysosomes in these cells is caused, at least in part, by defects in lysosomal ion homeostasis. Importantly, PI(3,5)P2 has been shown to activate ion channels on endosomes and lysosomes. TRPML1 is activated by binding of PI(3,5)P2 to its N-terminal region (Dong et al, 2010). Furthermore, PI(3,5)P2 promotes the activity of two-pore channel proteins (TPC1, TPC2), which mediate calcium release from endolysosomes to the cytosol (Wang et al, 2012). Moreover, vacuole acidification is impaired in fab1Δ and vac7Δ yeast (Yamamoto et al, 1995; Bonangelino et al, 1997), although an independent study suggests that the pH of the vacuole is unaffected in fab1Δ yeast (Ho et al, 2015). These studies suggest that PI(3,5)P2 is crucial for the regulation of specific ion channels on endosomes and lysosomes and possibly affects vacuole acidification as well. Effects on vacuolar pH may be due to direct regulation of the v-ATPase by PI(3,5)P2 (Li et al, 2014).

The Fab1/PIKfyve complex is involved in a variety of intracellular membrane traffic pathways. In yeast, the depletion of Vac7 suppresses retrograde transport between vacuoles and Golgi (Bryant et al, 1998). In addition, fab1Δ yeast cells exhibit multivesicular bodies that contain fewer intraluminal vesicles compared to wild-type cells (Gary et al, 1998). Similarly, depletion of PIKfyve or Vac14 in mammalian cells perturbs retrieval of the cation-independent mannose 6-phosphate receptor (CI-MPR) and sortilin from endosomes to the trans-Golgi network (TGN) (Rutherford et al, 2006; Zhang et al, 2007). Furthermore, PIKfyve suppression using siRNA or PIKfyve inhibitors changes the cellular distribution of CI-MPR and TGN46 (de Lartigue et al, 2009). These reports also identify a minor effect of PIKfyve inhibition on EGF receptor degradation, indicating that the mammalian PIKfyve complex has an important role in retrograde traffic between endosomes and the TGN. However, whether there is direct involvement of PIKfyve in the degradation pathway remains an open question.

The mechanistic target of rapamycin (mTOR) signaling pathway regulates many major cellular processes and defects in mTOR signaling are implicated in a large number of diseases including cancer, diabetes, and neurodegeneration (Laplante & Sabatini, 2012). mTORC1 is localized to lysosomes and is activated in response to growth factor stimulation to control cell growth and autophagy through regulatory proteins including TSC1/2 and Raptor. It has been shown that PI(3,5)P2 is required for TORC1 activity and the localization of TORC1 substrates in yeast (Jin et al, 2014). Moreover, PI(3,5)P2 plays a role in the lysosomal localization and activation of mTORC1 in adipocytes (Bridges et al, 2012), suggesting that PI(3,5)P2 is a regulator of mTORC1 in yeast and in at least some mammalian cell types.

Autophagy is an essential intracellular degradation system conserved from yeast to humans (Mizushima & Komatsu, 2011; Lamb et al, 2013; Shibutani & Yoshimori, 2014). Autophagosomes, which are generated under stress conditions including starvation, enclose cytosolic cargos such as proteins and organelles and facilitate their degradation through fusion with lysosomes. Inhibition of PIKfyve results in the accumulation of autophagosomes (de Lartigue et al, 2009; Martin et al, 2013). Brain tissue from Fig4−/− mice display an accumulation of the autophagosome marker LC3-II and the autophagy substrate p62 (Ferguson et al, 2009), implying that PI(3,5)P2 promotes autophagy. Given the role of PIKfyve in intracellular transport and lysosomal acidification, the phenotypes observed in these studies could be caused by a defect in autophagosome-lysosome fusion and/or lysosomal function. Interestingly, depletion of the PI 5-phosphatase INPP5E causes suppression of the fusion step between autophagosomes and lysosomes (Hasegawa et al, 2016). That INPP5E acts on PI(3,5)P2 in vitro, suggests that lysosomal PI(3,5)P2 is elevated during depletion of INPP5E. Notably, cortactin binds directly to PI(3,5)P2, which negatively regulates cortactin interactions with actin (Hong et al, 2015). Thus, elevation of PI(3,5)P2 may underlie the defects observed during depletion of INPP5E, namely defects in cortactin-actin association with lysosomes, and inhibition of autophagosome-lysosome fusion (Hasegawa et al, 2016). These studies suggest that proper production and turnover of PI(3,5)P2 are critical for the regulation of autophagy.

PIKfyve suppression impedes phagosome maturation but does not impair lysosomal acidification in macrophages (Kim et al, 2014). Additionally, PIKfyve facilitates the export of nutrients from vacuoles following engulfment of macromolecules (Krishna et al, 2016), indicating that PI(3,5)P2 plays an important role in the maturation of phagosomes as well as reuse of phagocytosed nutrients in macrophages.

Glutamate stimulation of neurons increases PI(3,5)P2 levels (McCartney et al, 2014b). Moreover, PIKfyve promotes the internalization and degradation of voltage-gated calcium channels in response to glutamate, leading to protection from excitotoxic cell death (Tsuruta et al, 2009). Vac14 is present at the synapse in hippocampal neurons and loss of Vac14 or Fig4 enhances excitatory synaptic function. In addition, surface levels of AMPA-type glutamate receptors are increased by the depletion of Vac14 due to reduced receptor endocytosis or an increase in receptor recycling (Zhang et al, 2012). Similarly, surface expression of AMPA-type glutamate receptors is reduced after treatment with PIKfyve inhibitors (Seebohm et al, 2012). Therefore, the PIKfyve complex and/or PI(3,5)P2 play important roles in regulating postsynaptic function through regulating the surface levels of glutamate receptors and channels.

Several mutations of Fig4 have been found in CMT4J, a specific type of Charcot-Marie-Tooth disease (Chow et al, 2007; Zhang et al, 2008). CMT4J causes damage to myelin sheaths and nerve fibers resulting in neuropathy (Nicholson & Myers, 2006). Patients with the common CMT4J mutation Fig4 isoleucine 41 to threonine (I41T), have a delay in motor development and reduced nerve conduction velocity (Chow et al, 2007). The corresponding yeast mutation, Fig4 I59T, results in reduced cellular PI(3,5)P2 levels (Chow et al, 2007). In addition, mutations in Vac14 have been associated with a progressive neurological disorder (Lenk et al, 2016). The PIKfyve-Vac14-Fig4 complex is therefore linked to human neurological disorders. While mutations in PIKfyve that are linked to neurological disorders have yet to be uncovered, mutations in PIKfyve have been linked to fleck corneal dystrophy, a syndrome with punctate corneal stromal opacities (Gee et al, 2015).

PI(3,5)P2 binding proteins

β-propellers that bind polyphosphoinositides (PROPPINs), a WD40 motif containing protein family, bind to both PI(3,5)P2 and PI3P (Dove et al, 2004; Jeffries et al, 2004). Yeast has three PROPPINs: Atg18, Atg21, and Hsv2. Atg18 is essential for autophagy, and several Atg18 mutations, including mutations that cannot bind PI(3,5)P2 or PI3P, cause defects in autophagy (Baskaran et al, 2012; Krick et al, 2012; Rieter et al, 2013). Furthermore, PI binding activity is required for Atg18 localization to vacuoles and proper maintenance of PI(3,5)P2 levels (Efe et al, 2007). Several reports show that Raptor (Bridges et al, 2012), Sorting nexin-2 (Carlton et al, 2005), ryanodine receptor 1 (Shen et al, 2009), and lysosomal ATPase ATP13A2 (Holemans et al, 2015) can bind PI(3,5)P2. However, these proteins do not bind PI(3,5)P2 specifically and have relatively weak affinity for PI(3,5)P2 (Table II). A construct harboring tandem repeats of ML1N is the only in vivo PI(3,5)P2 probe described to date (Li et al, 2013). However, the specificity of this probe is disputed (Hammond et al, 2015). Future work is required for the development and verification of a specific PI(3,5)P2 probe with an appropriate binding affinity.

Table II.

Binding proteins/domains to PI(3,5)P2

Proteins/domains Binding affinity References
TRPML ML1N PI(3,5)P2 > PI5P Li et al, 2013
Atg18, Atg21, Hsv2 PI3P, PI(3,5)P2 Baskaran et al, 2012
Krick et al, 2012
WIPI-1,-2 PI3P > PI(3,5)P2 Proikas-Cezanne et al, 2007
Proikas-Cezanne et al, 2015
Raptor WD40 domain PI(3,5)P2 > PI3P Bridges et al, 2012
Sorting nexin-2 PI3P > PI(3,5)P2 Carlton et al, 2005
Ryanodine receptor 1 PI3P, PI5P, PI(3,5)P2 > PI4P Shen et al, 2009
ATP13A2 PI(3,5)P2, Phosphatidic acid Holemans et al, 2015
Open in a new tab

Conclusions

This review covers some intracellular and physiological functions of PI5P and PI(3,5)P2. In metazoans, since the PIKfyve complex is implicated in the generation of both of these lipids, phenotypes observed upon depletion of the complex cannot yet be attributed to loss of PI(3,5)P2, PI5P, or both lipids. However, it is clear that both of these lipids play critical roles in physiology and pathology and a deeper understanding of metabolic pathways controlling production and turnover of PI5P and PI(3,5)P2 is imperative. The success of these studies will require the development of sensitive and specific cellular probes for both of these lipids, as well as methods that specifically raise or lower PI5P alone, as well as PI(3,5)P2 alone.

Acknowledgments

We apologize in advance to colleagues whose work was omitted due to space limitations. This study was supported in part by the Takeda Science Foundation (to J.H.), by a Jane Coffin Childs Memorial Fund fellowship and NIH K99GM-120511 (to B.S.S), and by NIH grants R01-NS064015 and R01-GM050403 (to L.S.W.).

Abbreviations

CI-MPR

cation-independent mannose 6-phosphate receptor

CMT

Charcot-Marie-Tooth

Dok

downstream of tyrosine kinase

EGF

epidermal growth factor

GEF

guanine nucleotide exchange factor

GLUT4

glucose transporter type 4

LPS

lipopolysaccharide

MEF

mouse embryonic fibroblast

mTOR

mechanistic target of rapamycin

MTMR

myotubularin related protein

PHD

plant homeodomain

PI

phosphoinositide

PI5P

phosphatidylinositol 5-phosphate

PI(3

5)P2, phosphatidylinositol 3,5-bisphosphate

PROPPIN

β-propeller that polyphosphoinositides

TCR

T cell receptor

TLR

Toll-like receptor

TPC

two-pore channel protein

TRPML

mucolipin transient receptor potential

WIPI

WD repeat domain phosphoinositide-interacting protein

References

  1. Acuto O, Di Bartolo V, Michel F. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat Rev Immunol. 2008;8:699–712. doi: 10.1038/nri2397. [DOI] [PubMed] [Google Scholar]
  2. Alghamdi TA, Ho CY, Mrakovic A, Taylor D, Mao D, Botelho RJ. Vac14 protein multimerization is a prerequisite step for Fab1 protein complex assembly and function. Journal of Biological Chemistry. 2013;288:9363–9372. doi: 10.1074/jbc.M113.453712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Backer JM. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem J. 2008;410:1–17. doi: 10.1042/BJ20071427. [DOI] [PubMed] [Google Scholar]
  4. Balla T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev. 2013;93:1019–1137. doi: 10.1152/physrev.00028.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baskaran S, Ragusa MJ, Boura E, Hurley JH. Two-site recognition of phosphatidylinositol 3-phosphate by PROPPINs in autophagy. Mol Cell. 2012;47:339–348. doi: 10.1016/j.molcel.2012.05.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baumeister MA, Martinu L, Rossman KL, Sondek J, Lemmon MA, Chou MM. Loss of phosphatidylinositol 3-phosphate binding by the C-terminal Tiam-1 pleckstrin homology domain prevents in vivo Rac1 activation without affecting membrane targeting. J Biol Chem. 2003;278:11457–11464. doi: 10.1074/jbc.M211901200. [DOI] [PubMed] [Google Scholar]
  7. Boal F, Mansour R, Gayral M, Saland E, Chicanne G, Xuereb J-M, Marcellin M, Burlet-Schiltz O, Sansonetti PJ, Payrastre B, Tronchère H. TOM1 is a PI5P effector involved in the regulation of endosomal maturation. J Cell Sci. 2015;128:815–827. doi: 10.1242/jcs.166314. [DOI] [PubMed] [Google Scholar]
  8. Boal F, Puhar A, Xuereb J-M, Kunduzova O, Sansonetti PJ, Payrastre B, Tronchère H. PI5P Triggers ICAM-1 Degradation in Shigella Infected Cells, Thus Dampening Immune Cell Recruitment. Cell Rep. 2016;14:750–759. doi: 10.1016/j.celrep.2015.12.079. [DOI] [PubMed] [Google Scholar]
  9. Bonangelino CJ, Catlett NL, Weisman LS. Vac7p, a novel vacuolar protein, is required for normal vacuole inheritance and morphology. Mol Cell Biol. 1997;17:6847–6858. doi: 10.1128/mcb.17.12.6847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bonangelino CJ, Nau JJ, Duex JE, Brinkman M, Wurmser AE, Gary JD, Emr SD, Weisman LS. Osmotic stress-induced increase of phosphatidylinositol 3,5-bisphosphate requires Vac14p, an activator of the lipid kinase Fab1p. J Cell Biol. 2002;156:1015–1028. doi: 10.1083/jcb.200201002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Botelho RJ, Efe JA, Teis D, Emr SD. Assembly of a Fab1 phosphoinositide kinase signaling complex requires the Fig4 phosphoinositide phosphatase. Mol Biol Cell. 2008;19:4273–4286. doi: 10.1091/mbc.E08-04-0405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bridges D, Ma J-T, Park S, Inoki K, Weisman LS, Saltiel AR. Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1. Mol Biol Cell. 2012;23:2955–2962. doi: 10.1091/mbc.E11-12-1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bryant NJ, Piper RC, Weisman LS, Stevens TH. Retrograde traffic out of the yeast vacuole to the TGN occurs via the prevacuolar/endosomal compartment. J Cell Biol. 1998;142:651–663. doi: 10.1083/jcb.142.3.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cabezas A, Pattni K, Stenmark H. Cloning and subcellular localization of a human phosphatidylinositol 3-phosphate 5-kinase, PIKfyve/Fab1. Gene. 2006;371:34–41. doi: 10.1016/j.gene.2005.11.009. [DOI] [PubMed] [Google Scholar]
  15. Cai X, Xu Y, Cheung AK, Tomlinson RC, Alcazar-Roman A, Murphy L, Billich A, Zhang B, Feng Y, Klumpp M, Rondeau J-M, Fazal AN, Wilson CJ, Myer V, Joberty G, Bouwmeester T, Labow MA, Finan PM, Porter JA, Ploegh HL, et al. PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling. Chem Biol. 2013;20:912–921. doi: 10.1016/j.chembiol.2013.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Carlton JG, Bujny MV, Peter BJ, Oorschot VMJ, Rutherford A, Arkell RS, Klumperman J, Mcmahon HT, Cullen PJ. Sorting nexin-2 is associated with tubular elements of the early endosome, but is not essential for retromer-mediated endosome-to-TGN transport. J Cell Sci. 2005;118:4527–4539. doi: 10.1242/jcs.02568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chow CY, Zhang Y, Dowling JJ, Jin N, Adamska M, Shiga K, Szigeti K, Shy ME, Li J, Zhang X, Lupski JR, Weisman LS, Meisler MH. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature. 2007;448:68–72. doi: 10.1038/nature05876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ciruela A, Hinchliffe KA, Divecha N, Irvine RF. Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7. Biochem J. 2000;346(Pt 3):587–591. [PMC free article] [PubMed] [Google Scholar]
  19. Clarke JH, Irvine RF. Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization. Biochem J. 2013;454:49–57. doi: 10.1042/BJ20130488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Clarke JH, Letcher AJ, D’santos CS, Halstead JR, Irvine RF, Divecha N. Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells. Biochem J. 2001;357:905–910. doi: 10.1042/0264-6021:3570905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cooke FT, Dove SK, McEwen RK, Painter G, Holmes AB, Hall MN, Michell RH, Parker PJ. The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p is essential for vacuole function in S. cerevisiae. Current Biology. 1998;8:1219–1222. doi: 10.1016/s0960-9822(07)00513-1. [DOI] [PubMed] [Google Scholar]
  22. Cossart P, Sansonetti PJ. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science. 2004;304:242–248. doi: 10.1126/science.1090124. [DOI] [PubMed] [Google Scholar]
  23. de Lartigue J, Polson H, Feldman M, Shokat K, Tooze SA, Urbé S, Clague MJ. PIKfyve regulation of endosome-linked pathways. Traffic. 2009;10:883–893. doi: 10.1111/j.1600-0854.2009.00915.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443:651–657. doi: 10.1038/nature05185. [DOI] [PubMed] [Google Scholar]
  25. Dong X-P, Shen D, Wang X, Dawson T, Li X, Zhang Q, Cheng X, Zhang Y, Weisman LS, Delling M, Xu H. PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat Commun. 2010;1:38–11. doi: 10.1038/ncomms1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Dove SK, Cooke FT, Douglas MR, Sayers LG, Parker PJ, Michell RH. Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis. Nature. 1997;390:187–192. doi: 10.1038/36613. [DOI] [PubMed] [Google Scholar]
  27. Dove SK, McEwen RK, Mayes A, Hughes DC, Beggs JD, Michell RH. Vac14 controls PtdIns(3,5)P(2) synthesis and Fab1-dependent protein trafficking to the multivesicular body. Current Biology. 2002;12:885–893. doi: 10.1016/s0960-9822(02)00891-6. [DOI] [PubMed] [Google Scholar]
  28. Dove SK, Piper RC, McEwen RK, Yu JW, King MC, Hughes DC, Thuring J, Holmes AB, Cooke FT, Michell RH, Parker PJ, Lemmon MA. Svp1p defines a family of phosphatidylinositol 3,5-bisphosphate effectors. EMBO J. 2004;23:1922–1933. doi: 10.1038/sj.emboj.7600203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Duex JE, Nau JJ, Kauffman EJ, Weisman LS. Phosphoinositide 5-phosphatase Fig 4p is required for both acute rise and subsequent fall in stress-induced phosphatidylinositol 3,5-bisphosphate levels. Eukaryotic Cell. 2006a;5:723–731. doi: 10.1128/EC.5.4.723-731.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Duex JE, Tang F, Weisman LS. The Vac14p-Fig4p complex acts independently of Vac7p and couples PI3,5P2 synthesis and turnover. J Cell Biol. 2006b;172:693–704. doi: 10.1083/jcb.200512105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Efe JA, Botelho RJ, Emr SD. Atg18 regulates organelle morphology and Fab1 kinase activity independent of its membrane recruitment by phosphatidylinositol 3,5-bisphosphate. Mol Biol Cell. 2007;18:4232–4244. doi: 10.1091/mbc.E07-04-0301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Eyster KM. The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist. Adv Physiol Educ. 2007;31:5–16. doi: 10.1152/advan.00088.2006. [DOI] [PubMed] [Google Scholar]
  33. Ferguson CJ, Lenk GM, Meisler MH. Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. Hum Mol Genet. 2009;18:4868–4878. doi: 10.1093/hmg/ddp460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Fernandis AZ, Wenk MR. Membrane lipids as signaling molecules. Curr Opin Lipidol. 2007;18:121–128. doi: 10.1097/MOL.0b013e328082e4d5. [DOI] [PubMed] [Google Scholar]
  35. Gary JD, Sato TK, Stefan CJ, Bonangelino CJ, Weisman LS, Emr SD. Regulation of Fab1 phosphatidylinositol 3-phosphate 5-kinase pathway by Vac7 protein and Fig4, a polyphosphoinositide phosphatase family member. Mol Biol Cell. 2002;13:1238–1251. doi: 10.1091/mbc.01-10-0498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Gary JD, Wurmser AE, Bonangelino CJ, Weisman LS, Emr SD. Fab1p is essential for PtdIns(3)P 5-kinase activity and the maintenance of vacuolar size and membrane homeostasis. J Cell Biol. 1998;143:65–79. doi: 10.1083/jcb.143.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Gee JA, Frausto RF, Chung D-WD, Tangmonkongvoragul C, Le DJ, Wang C, Han J, Aldave AJ. Identification of novel PIKFYVE gene mutations associated with Fleck corneal dystrophy. Mol Vis. 2015;21:1093–1100. [PMC free article] [PubMed] [Google Scholar]
  38. Gozani O, Karuman P, Jones DR, Ivanov D, Cha J, Lugovskoy AA, Baird CL, Zhu H, Field SJ, Lessnick SL, Villasenor J, Mehrotra B, Chen J, Rao VR, Brugge JS, Ferguson CG, Payrastre B, Myszka DG, Cantley LC, Wagner G, et al. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell. 2003;114:99–111. doi: 10.1016/s0092-8674(03)00480-x. [DOI] [PubMed] [Google Scholar]
  39. Grainger DL, Tavelis C, Ryan AJ, Hinchliffe KA. Involvement of phosphatidylinositol 5-phosphate in insulin-stimulated glucose uptake in the L6 myotube model of skeletal muscle. Pflugers Arch. 2011;462:723–732. doi: 10.1007/s00424-011-1008-4. [DOI] [PubMed] [Google Scholar]
  40. Guittard G, Gérard A, Dupuis-Coronas S, Tronchère H, Mortier E, Favre C, Olive D, Zimmermann P, Payrastre B, Nunès JA. Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells. J Immunol. 2009;182:3974–3978. doi: 10.4049/jimmunol.0804172. [DOI] [PubMed] [Google Scholar]
  41. Guittard G, Mortier E, Tronchère H, Firaguay G, Gérard A, Zimmermann P, Payrastre B, Nunès JA. Evidence for a positive role of PtdIns5P in T-cell signal transduction pathways. FEBS Lett. 2010;584:2455–2460. doi: 10.1016/j.febslet.2010.04.051. [DOI] [PubMed] [Google Scholar]
  42. Hammond GRV, Takasuga S, Sasaki T, Balla T. The ML1Nx2 Phosphatidylinositol 3,5-Bisphosphate Probe Shows Poor Selectivity in Cells. PLoS ONE. 2015;10:e0139957. doi: 10.1371/journal.pone.0139957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hasegawa J, Iwamoto R, Otomo T, Nezu A, Hamasaki M, Yoshimori T. Autophagosome-lysosome fusion in neurons requires INPP5E, a protein associated with Joubert syndrome. EMBO J. 2016;35:1853–1867. doi: 10.15252/embj.201593148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ho CY, Choy CH, Wattson CA, Johnson DE, Botelho RJ. The Fab1/PIKfyve phosphoinositide phosphate kinase is not necessary to maintain the pH of lysosomes and of the yeast vacuole. Journal of Biological Chemistry. 2015;290:9919–9928. doi: 10.1074/jbc.M114.613984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Holemans T, Sørensen DM, van Veen S, Martin S, Hermans D, Kemmer GC, Van den Haute C, Baekelandt V, Günther Pomorski T, Agostinis P, Wuytack F, Palmgren M, Eggermont J, Vangheluwe P. A lipid switch unlocks Parkinson’s disease-associated ATP13A2. Proc Natl Acad Sci USA. 2015;112:9040–9045. doi: 10.1073/pnas.1508220112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hong NH, Qi A, Weaver AM. PI(3,5)P2 controls endosomal branched actin dynamics by regulating cortactin-actin interactions. J Cell Biol. 2015;210:753–769. doi: 10.1083/jcb.201412127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ikonomov OC, Sbrissa D, Shisheva A. Localized PtdIns 3,5-P2 synthesis to regulate early endosome dynamics and fusion. Am J Physiol, Cell Physiol. 2006;291:C393–404. doi: 10.1152/ajpcell.00019.2006. [DOI] [PubMed] [Google Scholar]
  48. Ikonomov OC, Sbrissa D, Delvecchio K, Xie Y, Jin J-P, Rappolee D, Shisheva A. The phosphoinositide kinase PIKfyve is vital in early embryonic development: preimplantation lethality of PIKfyve−/− embryos but normality of PIKfyve+/− mice. Journal of Biological Chemistry. 2011;286:13404–13413. doi: 10.1074/jbc.M111.222364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Ikonomov OC, Sbrissa D, Dondapati R, Shisheva A. ArPIKfyve-PIKfyve interaction and role in insulin-regulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes. Exp Cell Res. 2007;313:2404–2416. doi: 10.1016/j.yexcr.2007.03.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Ikonomov OC, Sbrissa D, Ijuin T, Takenawa T, Shisheva A. Sac3 is an insulin-regulated phosphatidylinositol 3,5-bisphosphate phosphatase: gain in insulin responsiveness through Sac3 down-regulation in adipocytes. J Biol Chem. 2009;284:23961–23971. doi: 10.1074/jbc.M109.025361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ikonomov OC, Sbrissa D, Venkatareddy M, Tisdale E, Garg P, Shisheva A. Class III PI 3-kinase is the main source of PtdIns3P substrate and membrane recruitment signal for PIKfyve constitutive function in podocyte endomembrane homeostasis. Biochim Biophys Acta. 2015;1853:1240–1250. doi: 10.1016/j.bbamcr.2015.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Jefferies HBJ, Cooke FT, Jat P, Boucheron C, Koizumi T, Hayakawa M, Kaizawa H, Ohishi T, Workman P, Waterfield MD, Parker PJ. A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep. 2008;9:164–170. doi: 10.1038/sj.embor.7401155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Jeffries TR, Dove SK, Michell RH, Parker PJ. PtdIns-specific MPR pathway association of a novel WD40 repeat protein, WIPI49. Mol Biol Cell. 2004;15:2652–2663. doi: 10.1091/mbc.E03-10-0732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Jin N, Chow CY, Liu L, Zolov SN, Bronson R, Davisson M, Petersen JL, Zhang Y, Park S, Duex JE, Goldowitz D, Meisler MH, Weisman LS. VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse. EMBO J. 2008;27:3221–3234. doi: 10.1038/emboj.2008.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Jin N, Lang MJ, Weisman LS. Phosphatidylinositol 3,5-bisphosphate: regulation of cellular events in space and time. Biochem Soc Trans. 2016;44:177–184. doi: 10.1042/BST20150174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Jin N, Mao K, Jin Y, Tevzadze G, Kauffman EJ, Park S, Bridges D, Loewith R, Saltiel AR, Klionsky DJ, Weisman LS. Roles for PI(3,5)P2 in nutrient sensing through TORC1. Mol Biol Cell. 2014;25:1171–1185. doi: 10.1091/mbc.E14-01-0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Jones DR, Bultsma Y, Keune W-J, Halstead JR, Elouarrat D, Mohammed S, Heck AJ, D’Santos CS, Divecha N. Nuclear PtdIns5P as a transducer of stress signaling: an in vivo role for PIP4Kbeta. Mol Cell. 2006;23:685–695. doi: 10.1016/j.molcel.2006.07.014. [DOI] [PubMed] [Google Scholar]
  58. Jones DR, Foulger R, Keune W-J, Bultsma Y, Divecha N. PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation. FASEB J. 2013;27:1644–1656. doi: 10.1096/fj.12-218842. [DOI] [PubMed] [Google Scholar]
  59. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34:637–650. doi: 10.1016/j.immuni.2011.05.006. [DOI] [PubMed] [Google Scholar]
  60. Kawasaki T, Takemura N, Standley DM, Akira S, Kawai T. The second messenger phosphatidylinositol-5-phosphate facilitates antiviral innate immune signaling. Cell Host Microbe. 2013;14:148–158. doi: 10.1016/j.chom.2013.07.011. [DOI] [PubMed] [Google Scholar]
  61. Kim GHE, Dayam RM, Prashar A, Terebiznik M, Botelho RJ. PIKfyve inhibition interferes with phagosome and endosome maturation in macrophages. Traffic. 2014;15:1143–1163. doi: 10.1111/tra.12199. [DOI] [PubMed] [Google Scholar]
  62. Klionsky DJ, Cregg JM, Dunn WA, Emr SD, Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M, Ohsumi Y. A unified nomenclature for yeast autophagy-related genes. Dev Cell. 2003;5:539–545. doi: 10.1016/s1534-5807(03)00296-x. [DOI] [PubMed] [Google Scholar]
  63. Kondo T, Kawai T, Akira S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 2012;33:449–458. doi: 10.1016/j.it.2012.05.002. [DOI] [PubMed] [Google Scholar]
  64. Krick R, Busse RA, Scacioc A, Stephan M, Janshoff A, Thumm M, Kühnel K. Structural and functional characterization of the two phosphoinositide binding sites of PROPPINs, a β-propeller protein family. Proc Natl Acad Sci USA. 2012;109:E2042–9. doi: 10.1073/pnas.1205128109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Krishna S, Palm W, Lee Y, Yang W, Bandyopadhyay U, Xu H, Florey O, Thompson CB, Overholtzer M. PIKfyve Regulates Vacuole Maturation and Nutrient Recovery following Engulfment. Dev Cell. 2016;38:536–547. doi: 10.1016/j.devcel.2016.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Lamb CA, Yoshimori T, Tooze SA. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 2013 doi: 10.1038/nrm3696. [DOI] [PubMed] [Google Scholar]
  67. Lang MJ, Strunk BS, Azad N, Petersen JL, Weisman LS. An intramolecular interaction within the lipid kinase Fab1 regulates cellular phosphatidylinositol 3,5-bisphosphate lipid levels. Mol Biol Cell. 2017 doi: 10.1091/mbc.E16-06-0390. mbc.E16–06–0390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293. doi: 10.1016/j.cell.2012.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Lecompte O, Poch O, Laporte J. PtdIns5P regulation through evolution: roles in membrane trafficking? Trends Biochem Sci. 2008;33:453–460. doi: 10.1016/j.tibs.2008.07.002. [DOI] [PubMed] [Google Scholar]
  70. Leney SE, Tavaré JM. The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol. 2009;203:1–18. doi: 10.1677/JOE-09-0037. [DOI] [PubMed] [Google Scholar]
  71. Lenk GM, Ferguson CJ, Chow CY, Jin N, Jones JM, Grant AE, Zolov SN, Winters JJ, Giger RJ, Dowling JJ, Weisman LS, Meisler MH. Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. PLoS Genet. 2011;7:e1002104. doi: 10.1371/journal.pgen.1002104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Lenk GM, Szymanska K, Debska-Vielhaber G, Rydzanicz M, Walczak A, Bekiesinska-Figatowska M, Vielhaber S, Hallmann K, Stawinski P, Buehring S, Hsu DA, Kunz WS, Meisler MH, Ploski R. Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease. Am J Hum Genet. 2016;99:188–194. doi: 10.1016/j.ajhg.2016.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Li SC, Diakov TT, Xu T, Tarsio M, Zhu W, Couoh-Cardel S, Weisman LS, Kane PM. The signaling lipid PI(3,5)P2 stabilizes V1-V(o) sector interactions and activates the V-ATPase. Mol Biol Cell. 2014;25:1251–1262. doi: 10.1091/mbc.E13-10-0563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Li X, Wang X, Zhang X, Zhao M, Tsang WL, Zhang Y, Yau RGW, Weisman LS, Xu H. Genetically encoded fluorescent probe to visualize intracellular phosphatidylinositol 3,5-bisphosphate localization and dynamics. Proc Natl Acad Sci USA. 2013;110:21165–21170. doi: 10.1073/pnas.1311864110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Marcus SL, Wenk MR, Steele-Mortimer O, Finlay BB. A synaptojanin-homologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation. FEBS Lett. 2001;494:201–207. doi: 10.1016/s0014-5793(01)02356-0. [DOI] [PubMed] [Google Scholar]
  76. Martin S, Harper CB, May LM, Coulson EJ, Meunier FA, Osborne SL. Inhibition of PIKfyve by YM-201636 dysregulates autophagy and leads to apoptosis-independent neuronal cell death. PLoS ONE. 2013;8:e60152. doi: 10.1371/journal.pone.0060152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Mayinger P. Phosphoinositides and vesicular membrane traffic. Biochim Biophys Acta. 2012;1821:1104–1113. doi: 10.1016/j.bbalip.2012.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. McCartney AJ, Zhang Y, Weisman LS. Phosphatidylinositol 3,5-bisphosphate: low abundance, high significance. BioEssays: news and reviews in molecular, cellular and developmental biology. 2014a;36:52–64. doi: 10.1002/bies.201300012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. McCartney AJ, Zolov SN, Kauffman EJ, Zhang Y, Strunk BS, Weisman LS, Sutton MA. Activity-dependent PI(3,5)P2 synthesis controls AMPA receptor trafficking during synaptic depression. Proc Natl Acad Sci USA. 2014b;111:E4896–905. doi: 10.1073/pnas.1411117111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Meijer HJ, Berrie CP, Iurisci C, Divecha N, Musgrave A, Munnik T. Identification of a new polyphosphoinositide in plants, phosphatidylinositol 5-monophosphate (PtdIns5P), and its accumulation upon osmotic stress. Biochem J. 2001;360:491–498. doi: 10.1042/0264-6021:3600491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Min SH, Suzuki A, Stalker TJ, Zhao L, Wang Y, McKennan C, Riese MJ, Guzman JF, Zhang S, Lian L, Joshi R, Meng R, Seeholzer SH, Choi JK, Koretzky G, Marks MS, Abrams CS. Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice. Nat Commun. 2014;5:4691. doi: 10.1038/ncomms5691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728–741. doi: 10.1016/j.cell.2011.10.026. [DOI] [PubMed] [Google Scholar]
  83. Morris JB, Hinchliffe KA, Ciruela A, Letcher AJ, Irvine RF. Thrombin stimulation of platelets causes an increase in phosphatidylinositol 5-phosphate revealed by mass assay. FEBS Lett. 2000;475:57–60. doi: 10.1016/s0014-5793(00)01625-2. [DOI] [PubMed] [Google Scholar]
  84. Nicholson G, Myers S. Intermediate forms of Charcot-Marie-Tooth neuropathy: a review. Neuromol Med. 2006;8:123–130. doi: 10.1385/nmm:8:1-2:123. [DOI] [PubMed] [Google Scholar]
  85. Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, Sheetz MP, Parsot C, Sansonetti PJ, Payrastre B. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 2002;21:5069–5078. doi: 10.1093/emboj/cdf522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Norris FA, Wilson MP, Wallis TS, Galyov EE, Majerus PW. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci USA. 1998;95:14057–14059. doi: 10.1073/pnas.95.24.14057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Oppelt A, Lobert VH, Haglund K, Mackey AM, Rameh LE, Liestøl K, Schink KO, Pedersen NM, Wenzel EM, Haugsten EM, Brech A, Rusten TE, Stenmark H, Wesche J. Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration. EMBO Rep. 2013;14:57–64. doi: 10.1038/embor.2012.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Pendaries C, Tronchère H, Arbibe L, Mounier J, Gozani O, Cantley L, Fry MJ, Gaits-Iacovoni F, Sansonetti PJ, Payrastre B. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J. 2006;25:1024–1034. doi: 10.1038/sj.emboj.7601001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Proikas-Cezanne T, Ruckerbauer S, Stierhof Y-D, Berg C, Nordheim A. Human WIPI-1 puncta-formation: a novel assay to assess mammalian autophagy. FEBS Lett. 2007;581:3396–3404. doi: 10.1016/j.febslet.2007.06.040. [DOI] [PubMed] [Google Scholar]
  90. Proikas-Cezanne T, Takacs Z, Dönnes P, Kohlbacher O. WIPI proteins: essential PtdIns3P effectors at the nascent autophagosome. J Cell Sci. 2015;128:207–217. doi: 10.1242/jcs.146258. [DOI] [PubMed] [Google Scholar]
  91. Rameh LE, Tolias KF, Duckworth BC, Cantley LC. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature. 1997;390:192–196. doi: 10.1038/36621. [DOI] [PubMed] [Google Scholar]
  92. Ramel D, Lagarrigue F, Pons V, Mounier J, Dupuis-Coronas S, Chicanne G, Sansonetti PJ, Gaits-Iacovoni F, Tronchère H, Payrastre B. Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling. Science Signaling. 2011;4:ra61–ra61. doi: 10.1126/scisignal.2001619. [DOI] [PubMed] [Google Scholar]
  93. Rieter E, Vinke F, Bakula D, Cebollero E, Ungermann C, Proikas-Cezanne T, Reggiori F. Atg18 function in autophagy is regulated by specific sites within its β-propeller. J Cell Sci. 2013;126:593–604. doi: 10.1242/jcs.115725. [DOI] [PubMed] [Google Scholar]
  94. Roberts HF, Clarke JH, Letcher AJ, Irvine RF, Hinchliffe KA. Effects of lipid kinase expression and cellular stimuli on phosphatidylinositol 5-phosphate levels in mammalian cell lines. FEBS Lett. 2005;579:2868–2872. doi: 10.1016/j.febslet.2005.04.027. [DOI] [PubMed] [Google Scholar]
  95. Rudge SA, Anderson DM, Emr SD. Vacuole size control: regulation of PtdIns(3,5)P2 levels by the vacuole-associated Vac14-Fig4 complex, a PtdIns(3,5)P2-specific phosphatase. Mol Biol Cell. 2004;15:24–36. doi: 10.1091/mbc.E03-05-0297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Rutherford AC, Traer C, Wassmer T, Pattni K, Bujny MV, Carlton JG, Stenmark H, Cullen PJ. The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport. J Cell Sci. 2006;119:3944–3957. doi: 10.1242/jcs.03153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Samie M, Wang X, Zhang X, Goschka A, Li X, Cheng X, Gregg E, Azar M, Zhuo Y, Garrity AG, Gao Q, Slaugenhaupt S, Pickel J, Zolov SN, Weisman LS, Lenk GM, Titus S, Bryant-Genevier M, Southall N, Juan M, et al. A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev Cell. 2013;26:511–524. doi: 10.1016/j.devcel.2013.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Sarkes D, Rameh LE. A novel HPLC-based approach makes possible the spatial characterization of cellular PtdIns5P and other phosphoinositides. Biochem J. 2010;428:375–384. doi: 10.1042/BJ20100129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Sasaki T, Takasuga S, Sasaki J, Kofuji S, Eguchi S, Yamazaki M, Suzuki A. Mammalian phosphoinositide kinases and phosphatases. Progress in Lipid Research. 2009;48:307–343. doi: 10.1016/j.plipres.2009.06.001. [DOI] [PubMed] [Google Scholar]
  100. Sbrissa D, Shisheva A. Acquisition of unprecedented phosphatidylinositol 3,5-bisphosphate rise in hyperosmotically stressed 3T3-L1 adipocytes, mediated by ArPIKfyve-PIKfyve pathway. J Biol Chem. 2005;280:7883–7889. doi: 10.1074/jbc.M412729200. [DOI] [PubMed] [Google Scholar]
  101. Sbrissa D, Ikonomov OC, Shisheva A. PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. J Biol Chem. 1999;274:21589–21597. doi: 10.1074/jbc.274.31.21589. [DOI] [PubMed] [Google Scholar]
  102. Sbrissa D, Ikonomov OC, Deeb R, Shisheva A. Phosphatidylinositol 5-phosphate biosynthesis is linked to PIKfyve and is involved in osmotic response pathway in mammalian cells. J Biol Chem. 2002;277:47276–47284. doi: 10.1074/jbc.M207576200. [DOI] [PubMed] [Google Scholar]
  103. Sbrissa D, Ikonomov OC, Strakova J, Shisheva A. Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation. Endocrinology. 2004;145:4853–4865. doi: 10.1210/en.2004-0489. [DOI] [PubMed] [Google Scholar]
  104. Schaletzky J, Dove SK, Short B, Lorenzo O, Clague MJ, Barr FA. Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Current Biology. 2003;13:504–509. doi: 10.1016/s0960-9822(03)00132-5. [DOI] [PubMed] [Google Scholar]
  105. Schink KO, Tan K-W, Stenmark H. Phosphoinositides in Control of Membrane Dynamics. Annu Rev Cell Dev Biol. 2016;32:143–171. doi: 10.1146/annurev-cellbio-111315-125349. [DOI] [PubMed] [Google Scholar]
  106. Schu PV, Takegawa K, Fry MJ, Stack JH, Waterfield MD, Emr SD. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science. 1993;260:88–91. doi: 10.1126/science.8385367. [DOI] [PubMed] [Google Scholar]
  107. Seebohm G, Neumann S, Theiss C, Novkovic T, Hill EV, Tavaré JM, Lang F, Hollmann M, Manahan-Vaughan D, Strutz-Seebohm N. Identification of a novel signaling pathway and its relevance for GluA1 recycling. PLoS ONE. 2012;7:e33889. doi: 10.1371/journal.pone.0033889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Shen J, Yu W-M, Brotto M, Scherman JA, Guo C, Stoddard C, Nosek TM, Valdivia HH, Qu C-K. Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat Cell Biol. 2009;11:769–776. doi: 10.1038/ncb1884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Shibutani ST, Yoshimori T. A current perspective of autophagosome biogenesis. Cell Res. 2014;24:58–68. doi: 10.1038/cr.2013.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Shisheva A. PIKfyve: Partners, significance, debates and paradoxes. Cell Biol Int. 2008;32:591–604. doi: 10.1016/j.cellbi.2008.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Takasuga S, Horie Y, Sasaki J, Sun-Wada G-H, Kawamura N, Iizuka R, Mizuno K, Eguchi S, Kofuji S, Kimura H, Yamazaki M, Horie C, Odanaga E, Sato Y, Chida S, Kontani K, Harada A, Katada T, Suzuki A, Wada Y, et al. Critical roles of type III phosphatidylinositol phosphate kinase in murine embryonic visceral endoderm and adult intestine. Proc Natl Acad Sci USA. 2013;110:1726–1731. doi: 10.1073/pnas.1213212110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Takatori S, Tatematsu T, Cheng J, Matsumoto J, Akano T, Fujimoto T. Phosphatidylinositol 3,5-Bisphosphate-Rich Membrane Domains in Endosomes and Lysosomes. Traffic. 2016;17:154–167. doi: 10.1111/tra.12346. [DOI] [PubMed] [Google Scholar]
  113. Tronchère H, Laporte J, Pendaries C, Chaussade C, Liaubet L, Pirola L, Mandel J-L, Payrastre B. Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J Biol Chem. 2004;279:7304–7312. doi: 10.1074/jbc.M311071200. [DOI] [PubMed] [Google Scholar]
  114. Tsujita K, Itoh T. Phosphoinositides in the regulation of actin cortex and cell migration. Biochim Biophys Acta. 2015;1851:824–831. doi: 10.1016/j.bbalip.2014.10.011. [DOI] [PubMed] [Google Scholar]
  115. Tsujita K, Itoh T, Ijuin T, Yamamoto A, Shisheva A, Laporte J, Takenawa T. Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J Biol Chem. 2004;279:13817–13824. doi: 10.1074/jbc.M312294200. [DOI] [PubMed] [Google Scholar]
  116. Tsuruta F, Green EM, Rousset M, Dolmetsch RE. PIKfyve regulates CaV1.2 degradation and prevents excitotoxic cell death. J Cell Biol. 2009;187:279–294. doi: 10.1083/jcb.200903028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Ungewickell A, Hugge C, Kisseleva M, Chang S-C, Zou J, Feng Y, Galyov EE, Wilson M, Majerus PW. The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases. Proc Natl Acad Sci USA. 2005;102:18854–18859. doi: 10.1073/pnas.0509740102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Vaccari I, Dina G, Tronchère H, Kaufman E, Chicanne G, Cerri F, Wrabetz L, Payrastre B, Quattrini A, Weisman LS, Meisler MH, Bolino A. Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. PLoS Genet. 2011;7:e1002319. doi: 10.1371/journal.pgen.1002319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9:112–124. doi: 10.1038/nrm2330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Viaud J, Lagarrigue F, Ramel D, Allart S, Chicanne G, Ceccato L, Courilleau D, Xuereb J-M, Pertz O, Payrastre B, Gaits-Iacovoni F. Phosphatidylinositol 5-phosphate regulates invasion through binding and activation of Tiam1. Nat Commun. 2014;5:4080. doi: 10.1038/ncomms5080. [DOI] [PubMed] [Google Scholar]
  121. Vicinanza M, Korolchuk VI, Ashkenazi A, Puri C, Menzies FM, Clarke JH, Rubinsztein DC. PI(5)P regulates autophagosome biogenesis. Mol Cell. 2015;57:219–234. doi: 10.1016/j.molcel.2014.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Wang X, Zhang X, Dong X-P, Samie M, Li X, Cheng X, Goschka A, Shen D, Zhou Y, Harlow J, Zhu MX, Clapham DE, Ren D, Xu H. TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes. Cell. 2012;151:372–383. doi: 10.1016/j.cell.2012.08.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Watanabe Y, Kobayashi T, Yamamoto H, Hoshida H, Akada R, Inagaki F, Ohsumi Y, Noda NN. Structure-based analyses reveal distinct binding sites for Atg2 and phosphoinositides in Atg18. Journal of Biological Chemistry. 2012;287:31681–31690. doi: 10.1074/jbc.M112.397570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Yamamoto A, DeWald DB, Boronenkov IV, Anderson RA, Emr SD, Koshland D. Novel PI(4)P 5-kinase homologue, Fab1p, essential for normal vacuole function and morphology in yeast. Mol Biol Cell. 1995;6:525–539. doi: 10.1091/mbc.6.5.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Zhang X, Chow CY, Sahenk Z, Shy ME, Meisler MH, Li J. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain. 2008;131:1990–2001. doi: 10.1093/brain/awn114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Zhang Y, McCartney AJ, Zolov SN, Ferguson CJ, Meisler MH, Sutton MA, Weisman LS. Modulation of synaptic function by VAC14, a protein that regulates the phosphoinositides PI(3,5)P2 and PI(5)P. EMBO J. 2012;31:3442–3456. doi: 10.1038/emboj.2012.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS. Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci USA. 2007;104:17518–17523. doi: 10.1073/pnas.0702275104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Zolov SN, Bridges D, Zhang Y, Lee W-W, Riehle E, Verma R, Lenk GM, Converso-Baran K, Weide T, Albin RL, Saltiel AR, Meisler MH, Russell MW, Weisman LS. In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc Natl Acad Sci USA. 2012;109:17472–17477. doi: 10.1073/pnas.1203106109. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES